Charles McNerney
Directeur/Bestuurslid bij HAPBEE TECHNOLOGIES, INC.
Vermogen: - $ op 30-04-2024
Profiel
Charles E.
McNerney is an Independent Director at EMulate Therapeutics, Inc. and Hapbee Technologies, Inc. He was the Chief Information Security Officer at Microsoft Corp.
from 1993 to 2019 and the Chief Information Security Officer & VP at Expedia Group, Inc. from 2019 to 2022.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-10-2022 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Charles McNerney
| Bedrijven | Functie | Begin |
|---|---|---|
| HAPBEE TECHNOLOGIES, INC. | Directeur/Bestuurslid | 22-05-2019 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Directeur/Bestuurslid | 01-01-2016 |
Eerdere bekende functies van Charles McNerney
| Bedrijven | Functie | Einde |
|---|---|---|
| EXPEDIA GROUP, INC. | Corporate Officer/Principal | 01-03-2022 |
| MICROSOFT CORPORATION | Corporate Officer/Principal | 01-11-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| HAPBEE TECHNOLOGIES, INC. | Electronic Technology |
| EXPEDIA GROUP, INC. | Consumer Services |
| MICROSOFT CORPORATION | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
